Peptide Blends

Mod GRF 1-29 & Ipamorelin Blend

The gold standard research peptide stack: Mod GRF 1-29 (CJC-1295 no DAC) combined with ipamorelin for synergistic, selective, physiologically-patterned GH release.

C152H252N44O42S / C38H49N9O5Half-life: Mod GRF: ~30-60 min; Ipamorelin: ~2 hours

Community Rating

No ratings yet

⚠ Research & Educational Use Only. Mod GRF 1-29 & Ipamorelin Blend is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.

Medically reviewed by Dr. Amanda Haslett, MBChB MRCGPWritten by the KnowYourPeptide Research TeamLast updated April 2026
Our editorial standards →
Key Takeaways
  • Considered gold standard GH research combination
  • Physiological GH pulses with high selectivity (minimal cortisol/prolactin)
  • 3-4x GH amplitude vs either peptide alone
  • Mod GRF 1-29 & Ipamorelin Blend is not FDA-approved for human use. It is a research chemical for scientific study only.

Research At a Glance

  • Considered gold standard GH research combination
  • Physiological GH pulses with high selectivity (minimal cortisol/prolactin)
  • 3-4x GH amplitude vs either peptide alone
  • No motilin-related appetite stimulation (unlike GHRP-6 combinations)

What is Mod GRF 1-29 & Ipamorelin Blend?

Tap any underlined term for an instant definition.

The Mod GRF 1-29 & Ipamorelin Blend is considered the most selective and widely studied GH-stimulating peptide combination in the research literature. It combines the improved stability of Mod GRF 1-29 (CJC-1295 no DAC) with ipamorelin's unmatched GH selectivity among GHSPs, producing synergistic GH pulses with minimal off-target hormonal effects.

What It Is

  • Mod GRF 1-29: analogue with 4-substitution DPP-IV resistance; physiological preserved
  • Ipamorelin: the most selective available; minimal cortisol, prolactin, or appetite effects
  • The combination most frequently referenced in peer-reviewed GH secretagogue research
  • Often called the "gold standard" + research stack

How It Works

  • Mod GRF 1-29 activates GHRHR, producing direct somatotroph stimulation
  • Ipamorelin activates GHS-R1a and suppresses hypothalamic somatostatin
  • Combined GH pulse: 3-4x either peptide alone; pharmacokinetically matched (both short-acting)
  • No appetite stimulation (ipamorelin lacks motilin receptor activity)
  • Selectivity: cortisol and prolactin remain within normal range at standard research doses

Key Research Findings

  • increase: 50-70% from baseline with 3 months daily twice-daily administration
  • Body composition: 2-3 kg lean mass increase and 2% fat mass reduction at 6 months (research extrapolation from component studies)
  • Tachyphylaxis: No significant receptor desensitization at standard doses over 6-month monitoring periods
  • Comparative: Matched studies show ipamorelin produces 15% less cortisol elevation than GHRP-2 and 40% less than GHRP-6 at equivalent GH-stimulating doses

Dosing From the Literature

  • Mod GRF 1-29 100-200 mcg + Ipamorelin 200-300 mcg per injection
  • Twice daily: morning fasted + bedtime; or three times daily for intensive research protocols

Storage and Handling

  • Lyophilised: 2-8 degrees C; 24 months
  • : 2-8 degrees C; use within 30 days

Key Research Benefits

Documented effects observed in preclinical and clinical studies on Mod GRF 1-29 & Ipamorelin Blend. See all Peptide Blends peptides for comparison.

Considered gold standard GH research combination
Physiological GH pulses with high selectivity (minimal cortisol/prolactin)
3-4x GH amplitude vs either peptide alone
No motilin-related appetite stimulation (unlike GHRP-6 combinations)

Side Effects & Risks

Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports. View all peptides' side effects →

Dosing Data from the Literature

Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.

Research Dosing Protocol

Mod GRF 1-29 100-200 mcg + ipamorelin 200-300 mcg per injection. 2-3 times daily.

Enter your vial size and target dose to get the exact injection volume.

Administration in Research Settings

Standard reconstitution and administration methodology for laboratory research use.

on empty stomach. Best administered at bedtime and upon waking.

Explore Further

Quick Reference

Half-Life
Mod GRF: ~30-60 min; Ipamorelin: ~2 hours
Formula
C152H252N44O42S / C38H49N9O5
Legal Status
Research chemicals. Not approved for human use.
Storage
Lyophilised: 2-8 degrees C. Reconstituted: 2-8 degrees C; use within 30 days.

Research Use Only

This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.

AI Peptide Advisor

online · Claude + Gemini
ask your question...